Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
13.18
-2.08 (-13.63%)
Apr 29, 2026, 11:58 AM EDT - Market open
Anika Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 41.02 | 57.48 | 55.63 | 68.74 | 86.33 | 94.39 | Upgrade
|
| Cash & Short-Term Investments | 41.02 | 57.48 | 55.63 | 68.74 | 86.33 | 94.39 | Upgrade
|
| Cash Growth | -23.14% | 3.33% | -19.07% | -20.37% | -8.54% | -4.00% | Upgrade
|
| Receivables | 25.77 | 23.69 | 23.59 | 26.36 | 34.63 | 29.84 | Upgrade
|
| Inventory | 22.84 | 18.79 | 23.81 | 24.43 | 39.77 | 36.01 | Upgrade
|
| Prepaid Expenses | 3.94 | 3.4 | 5.49 | 7.48 | 8.83 | 8.29 | Upgrade
|
| Other Current Assets | - | - | 5.13 | 36.31 | - | - | Upgrade
|
| Total Current Assets | 93.56 | 103.36 | 113.65 | 163.31 | 169.55 | 168.53 | Upgrade
|
| Property, Plant & Equipment | 65.15 | 66.26 | 64.68 | 65 | 78.98 | 68.56 | Upgrade
|
| Goodwill | 7.89 | 8.05 | 7.13 | 7.57 | 7.34 | 7.78 | Upgrade
|
| Other Intangible Assets | 1.65 | 1.65 | 2.49 | 2.58 | 74.6 | 82.38 | Upgrade
|
| Long-Term Deferred Tax Assets | 1.15 | 1.28 | 1.18 | 1.49 | 1.45 | - | Upgrade
|
| Other Long-Term Assets | 4.3 | 4.03 | 7.68 | 30.69 | 17.22 | 20.29 | Upgrade
|
| Total Assets | 179.39 | 190.27 | 202.74 | 270.63 | 349.13 | 347.54 | Upgrade
|
| Accounts Payable | 6.34 | 6.04 | 5.62 | 6.19 | 9.07 | 7.63 | Upgrade
|
| Accrued Expenses | 14.63 | 13.82 | 11.59 | 11 | 15.96 | 16.13 | Upgrade
|
| Current Portion of Leases | - | 2.05 | 1.92 | 1.83 | 2.07 | 1.71 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.06 | 1.24 | 0.81 | - | Upgrade
|
| Other Current Liabilities | - | - | 4.12 | 10.8 | - | 4.32 | Upgrade
|
| Total Current Liabilities | 20.97 | 21.91 | 23.31 | 31.06 | 27.91 | 29.8 | Upgrade
|
| Long-Term Leases | 23.79 | 24.2 | 24.01 | 25.92 | 28.82 | 19.24 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 6.44 | 10.16 | Upgrade
|
| Other Long-Term Liabilities | 0.73 | 0.7 | 1.43 | 1.39 | 0.4 | 1.26 | Upgrade
|
| Total Liabilities | 45.49 | 46.81 | 48.75 | 58.37 | 63.57 | 60.45 | Upgrade
|
| Common Stock | 0.13 | 0.14 | 0.14 | 0.15 | 0.15 | 0.14 | Upgrade
|
| Additional Paid-In Capital | 83.35 | 87.5 | 88.96 | 90.01 | 81.14 | 67.08 | Upgrade
|
| Retained Earnings | 55.73 | 60.79 | 71.67 | 128.05 | 210.72 | 225.58 | Upgrade
|
| Comprehensive Income & Other | -5.31 | -4.96 | -6.78 | -5.94 | -6.44 | -5.72 | Upgrade
|
| Shareholders' Equity | 133.9 | 143.47 | 153.99 | 212.27 | 285.56 | 287.09 | Upgrade
|
| Total Liabilities & Equity | 179.39 | 190.27 | 202.74 | 270.63 | 349.13 | 347.54 | Upgrade
|
| Total Debt | 23.79 | 26.25 | 25.93 | 27.74 | 30.89 | 20.95 | Upgrade
|
| Net Cash (Debt) | 17.23 | 31.23 | 29.7 | 41 | 55.44 | 73.43 | Upgrade
|
| Net Cash Growth | -38.33% | 5.17% | -27.57% | -26.05% | -24.51% | -3.19% | Upgrade
|
| Net Cash Per Share | 1.22 | 2.18 | 2.02 | 2.80 | 3.81 | 5.02 | Upgrade
|
| Filing Date Shares Outstanding | 13.53 | 13.4 | 14.18 | 14.66 | 14.63 | 14.47 | Upgrade
|
| Total Common Shares Outstanding | 13.53 | 13.89 | 14.42 | 14.66 | 14.63 | 14.44 | Upgrade
|
| Working Capital | 72.6 | 81.45 | 90.35 | 132.25 | 141.63 | 138.73 | Upgrade
|
| Book Value Per Share | 9.90 | 10.33 | 10.68 | 14.48 | 19.53 | 19.88 | Upgrade
|
| Tangible Book Value | 124.36 | 133.76 | 144.37 | 202.12 | 203.63 | 196.92 | Upgrade
|
| Tangible Book Value Per Share | 9.19 | 9.63 | 10.01 | 13.79 | 13.92 | 13.64 | Upgrade
|
| Machinery | - | 51.2 | 42.9 | 44.39 | 54.53 | 51.19 | Upgrade
|
| Construction In Progress | - | 3.73 | 6.04 | 2.39 | 5.02 | 1.38 | Upgrade
|
| Leasehold Improvements | - | 36.82 | 36.34 | 34.65 | 34.92 | 34.61 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.